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Abstract 
Strangles is a contagious disease caused by the bacteria Streptococcus equi that 
has continued to affect horses through the development of long-term asymptomatic 
carriers.  Effective identification of horses carrying S. equi and treatment of these horses 
has proven difficult.  The chemical N-acetylcysteine (NAC) has mucolytic properties and 
has been used in the treatment of carriers; however the reports show controversial and 
anecdotal evidence regarding the effectiveness and inflammatory side effects.  The goal 
of this study is to observe whether NAC is irritating to mucosal tissue with the interest of 
determining if NAC could be used to treat the carrier state of Strangles.  Ten, healthy 
Standardbred mares were used in this random study which involved the endoscopic 
evaluation of uterine tissue in response to one of three treatment groups; no infusion, 
Lactated Ringer’s Solution (LRS), or a 3.3% NAC solution.  The collected endoscopic 
images were subjectively evaluated for signs of tissue irritation by a double-blinded 
researcher. The results from this study indicate that the uterine tissues showed minor 
inflammation for the treatment groups of LRS and NAC when compared to the no 
infusion group, and NAC showed fewer signs of inflammation when compared to LRS.  
These results indicate that NAC may have anti-inflammatory properties.   
 
 
 
 
 
 
 
 
 
 
 iv 
 
 
 
Acknowledgements  
 I send my deepest thank-you to Dr. Robert Causey for advising me throughout 
this project and introducing me to the field of veterinary research.  I also want to thank 
Elizabeth Turner and other AVS students for their assistance with this project as well as 
the University of Maine Standardbred mares for being so cooperative with this study.  
Additionally, I would like to thank the members of my Thesis Committee and AVS 
Capstone professors for your guidance, support, and revisions throughout this project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
Table of Contents 
 
1. Strangles Disease        1 
       
2. N-acetylcysteine         4 
  
3. Objective         7 
 
4. Material and Methods       8 
 
4.1 – Randomization of Horses     8 
 
4.2 – Preparation of Infusions     9 
 
4.3 – Irrigation Procedure      9 
 
4.4 – Endoscopy Procedure       10 
 
5. Results         10 
 
6. Discussion         19 
 
7. Conclusions and Implications      22 
  
8. References        23 
 
Appendix 1 – IACUC Approval       26 
 
Biography of the Author       36 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
List of Tables and Figures  
 
 
Table 1: Process of Randomization      9 
 
Table 2: Subjective Evaluation of Endoscopic Images  
    of the Uterus       12 
 
Table 3: The Relationship between Uterine Image  
    Scores and Treatment Group     13 
 
Figure 1 - Horse #1        14 
 
Figure 2 - Horse #2        14 
 
Figure 3 - Horse #3        15 
 
Figure 4 - Horse #4        15 
 
Figure 5 - Horse #5        16 
 
Figure 6 - Horse #6        16 
 
Figure 7 - Horse #7        17 
 
Figure 8 - Horse #8        17 
 
Figure 9 - Horse #9        18 
 
 Figure 10 - Horse #10        18 
 
 Figure 11 – Image Captured from Video of Horse #3   19 
 
 
 
 
 
 
 
 1 
 
 
1. Strangles Disease 
Strangles is an upper respiratory disease of equid species that is caused by the 
bacterium Streptococcus equi.  Strangles is an economically significant disease due to the 
extensive welfare costs and quarantine protocols that result as a consequence of this 
infection.  The S. equi bacteria can be transmitted to other horses by direct contact or 
indirectly through fomite and environmental contamination.  Strangles therefore is a very 
contagious disease with an infection rate of 85-100% for horses that come in contact with 
S. equi bacteria (Taylor and Wilson, 2006).  Upon coming in contact with this organism, 
there is a 3-8 day incubation period before clinical signs develop (Taylor and Wilson, 
2006).  Clinical signs of strangles include a fever greater than 103 F, swelling and 
abscess formation of lymph nodes, mucopurulent nasal discharge, and local inflammation 
and edema.  These signs can persist for 3-4 weeks and bacteria can be shed for an 
additional 4 week period after clinical signs dissipate (Taylor and Wilson, 2006; Sweeney 
et al., 2005).  
 
There are many complications of strangles that can raise the mortality rate from 
the average of 8-10 percent (Holland et al., 2006; Sweeney et al., 2005; Newton et al., 
1997) to nearly 40 percent (Sweeney et al., 2005).  Approximately 20% of horses can 
have complications from strangles (Sweeney et al., 2005).  Two major complications 
include; “bastard strangles” - the systemic abscessation of lymph tissues, and purpura 
haemorrhagica - an immune initiated hypersensitivity resulting in vasculitis. 
Additionally, another 10% of infected horses, and in some outbreaks this is much higher 
(Knowles et al., 2010; Newton et al., 2000), will become asymptomatic carriers of S. equi 
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for extended periods of time (Waller et al., 2011; Rosser et al., 2007; Taylor and Wilson, 
2006; Sweeney et al., 2005).   
 
Streptococcus equi has several virulent factors that shield the bacteria from the 
immune system and prevent phagocytosis and opsonization of the bacteria.  The immune 
system responds to the presence of S. equi by concentrating neutrophils in the lymph 
tissues.  This accumulation leads to the swelling of lymph nodes and can lead to abscess 
formation.  The guttural pouch carrier state is established when the retropharyngeal 
lymph nodes abscess and drain into the guttural pouch (Waller et al., 2011).  Once in the 
guttural pouch, S. equi and mucus can solidify into masses called chondroids and be 
present months later.  A study by Newton et al. (1997) found that 5 out of 6 carriers of 
strangles harbored S. equi bacteria in the guttural pouch for 7 to 34 months, allowing 
undetected carriers to intermittently shed S. equi after the initial infection (Newton  et al., 
2000).  Streptococcus equi has a short life span outside of the horse, and it is this 
prolonged carrier state that has allowed for this disease to be maintained within the equid 
population (Waller et al., 2011).  
 
A horse who is displaying clinical signs of strangles should be immediately 
isolated from the rest of the barn and other horses should be closely monitored for signs 
of infection.  A veterinarian should confirm the diagnosis using a PCR test, bacterial 
culture, or ELISA blood test.  Strangles treatment options range from letting the horse 
naturally fight the disease, to providing supportive care or antimicrobials based on the 
severity of the symptoms.  The most commonly used antibiotic for horses with strangles 
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is penicillin.  A positive S. equi horse should remain in isolation, following strict 
biosecurity protocols, until all clinical signs have subsided and the horse is verified as 
strangles free.  Biosecurity measures include halting the movement of animals onto or off 
of the farm, preventing cross contamination between the isolation area and the rest of the 
farm, following strict hygiene measures for caretakers, and properly cleaning and 
sanitizing the facilities and equipment.  A complete biosecurity protocol can be 
referenced from Holland et al. (2006), Taylor and Wilson (2006), or Sweeney et al. 
(2005).  Horses are typically deemed S. equi free after three consecutive negative 
cultures, taken at least one week apart, and a negative PCR test.  The PCR tests are used 
in conjunction with cultures due to their higher sensitivity when compared to 
nasopharyngeal swab cultures or guttural pouch lavage cultures, but also because PCR 
tests cannot differentiate between live and dead bacteria due to their assessment of DNA 
(Newton et al., 1997; 2000).  
 
Holland and many others also recommend that the guttural pouches of infected 
horses be cleaned out, treated, and confirmed negative for S. equi before an animal is 
reintegrated into the herd (Holland et al., 2006; Taylor and Wilson, 2006; Sweeney et al., 
2005).  The guttural pouches are two blind, air-filled sacs off of the auditory tube in the 
head of a horse.  Each sac has a volume of 300-500 milliliters (Baptiste et al., 2000; 
Chiesa et al., 1999) and is believed to facilitate temperature regulation of brain blood 
flow during extensive exercise as shown by Baptiste et al. (2000).  It is important to 
confirm that the guttural pouches are S. equi negative to help prevent the carrier state and 
thus reduce the future incidence rate of strangles.  There is also a need for the production 
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of safe and effective vaccines to help prevent strangles infections.  Although several 
vaccines are available, safety concerns due to adverse reactions and partial protectiveness 
have limited vaccine use to only at-risk horses (Waller and Jolley, 2007).  A new vaccine 
recently tested by Guss et al. (2009) holds promise for providing effective protection 
against strangles.  The 7-component vaccine includes two IgG endopeptidase antigens 
and provides 85% protection when challenged with S. equi (Guss et al., 2009).   
 
2. N-acetylcysteine 
N-acetylcysteine (NAC) is a drug with multiple purposes; it is a mucolytic agent, 
an anti-oxidant, a free radical scavenger, and can bind metals into complexes (Reinero et 
al., 2011; Atkuri et al., 2007; Thorne Research Inc., 2002).  Routes of administration for 
NAC include oral, intravenously, or as an aerosol (Atkuri et al., 2007) with side effects 
ranging from nausea and vomiting, to bronchospasm, and to anaphylactic shock (Levine 
and LoVecchio, 2011; Henke and Ratjen, 2007).  According to the package insert for 
acetylcysteine 20% solution, using this chemical as an aerosol will result in mucolytic 
responses which may be helpful in the treatment of the carrier state of strangles 
(American Regent Inc., 2005).   
 
N-acetylcysteine is primarily used in the medical industry to treat acetaminophen 
overdoses.  Acetaminophen is the pain and fever reducing chemical found in Tylenol, 
Percocet, and Vicodin (Levine and LoVecchio, 2011).  Acetaminophen is metabolized by 
the liver into N-acetyl-p-benzoquinoneimine – a toxic compound that is usually 
neutralized by glutathione.  Glutathione is a compound that maintains oxidative-reductive 
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balance in the body (Atkuri et al., 2007).  Overdosing with acetaminophen leads to a 
deficiency of glutathione, which causes N-acetyl-p-benzoquinoneimine accumulation in 
the liver resulting in hepatotoxicity (Levine and LoVecchio, 2011).  Acetaminophen 
overdoses are treated with a 5% oral NAC solution and acts to prevent hepatotoxicity 
through replenishing glutathione levels, or more directly through supplying cysteines - 
the precursor to glutathione (Atkuri et al., 2007; American Regent Inc., 2005).  Treatment 
with NAC is most effective within 8 hours of overdose (Levine and LoVecchio, 2011; 
Thorne Research Inc., 2002).  
 
Another medical use of NAC utilizes the mucolytic properties of this chemical as 
therapeutic treatment for patients with cystic fibrosis.  Cystic fibrosis is a condition 
caused by the malfunction of the chloride ion transporter resulting in dehydrated 
respiratory secretions and mucus accumulation (Henke and Ratjen, 2007).  Patients with 
cystic fibrosis receive NAC in an aerosol form to thin respiratory mucus.  Mucus contains 
a disulfide bond, which is broken by the thiol group of NAC causing a reduction in 
viscosity of respiratory mucus (Reinero et al., 2011; Henke and Ratjen, 2007; Thorne 
Research, 2002).  Although NAC has been proven to effectively breakdown mucus and 
has been shown to reduce inflammation in the lungs of patients with cystic fibrosis 
(Atkuri et al., 2007), it is no longer recommended for use because thinner mucus is more 
difficult to expel from airways and there is also concern about the risk of exposing a 
patient to bacteria that may be trapped in the mucus (Henke and Ratjen, 2007).  
 
6 
 
In the veterinary field, NAC is used to treat acetaminophen overdoses in cats and 
has been tested for other uses as well.  A recent experiment by Reinero et al. (2011) has 
assessed the safety of using NAC as a relief for asthmatic cats.  Asthma is characterized 
by increased airway inflammation and mucus secretion (Reinero et al., 2011).  The cats 
were sedated, given 400 mg of a 10% NAC solution and monitored for airway resistance 
by a ventilator.  Reinero et al. (2011) found that administration of NAC increased airway 
resistance.  
 
Additionally, NAC has been tested in the uterus of the horse as a treatment for 
reducing post-breeding endometritus.  Many mares suffer low fertility as a result from 
post-breeding inflammation of the uterine lining and delayed uterine clearance (Melkus et 
al., 2011).  A previous University of Maine Honors College student measured 
inflammatory responses of the uterus to the treatment of NAC or saline using cytology 
and biopsy methods (McGhie - unpublished).  Although these results were inconclusive, 
a more recent study by Melkus et al. (2011), which also measured inflammatory 
responses with cytology and biopsy procedures, has shown NAC to be beneficial.  
Melkus et al. (2011) irrigated the uteri of horses with either a 5% NAC solution or saline 
and evaluated for inflammatory responses at either 24 or 72 hours after irrigation.  This 
study found that irrigations of 5% NAC did not cause negative epithelial tissue effects in 
the uterus and was anti-inflammatory when compared to tissue responses from saline 
treatment (Melkus et al., 2011).   
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In equine medicine, the use of NAC has been reported in the treatment of guttural 
pouch diseases that result in empyema - the accumulation of pus (Sweeney et al., 2005; 
Perkins et al., 2003; Carmalt, 2002).  Strangles is one of the diseases where the use of 
NAC has been noted.  It is controversial whether there are additional benefits to including 
NAC into a guttural pouch lavage solution, or if the physical flushing provides the 
greatest benefit (Perkins et al., 2003).  Perkins et al. (2003) discourages the use of NAC 
in the guttural pouches due to “harmful and serious adverse effects.”  Conversely, Bentz 
et al. (1996) successfully treated a S. equi infected horse using NAC without negative 
side effects.  In this case study, the right guttural pouch was filled with thick purulent 
fluid which responded well to saline lavages.  The left guttural pouch however contained 
a chondroid and did not dissolve after five saline lavages.  In an attempt to avoid surgery, 
a lavage of 20% NAC was used to dissolve the chondroid.  After four lavages of 20% 
NAC, the chondroid was completely dissolved as verified by endoscopy.  The horse 
involved in the case study by Bentz et al. (1996) experienced no negative side effects 
from NAC.  The common side effects noted by other authors in association with the 
administration of NAC in horses are dysphagia- difficulty swallowing, and erythema- 
redness and inflammation (Sweeney et al., 2005; Perkins et al., 2003).  
 
3. Objective 
 In this study, endoscopy will be used to visually describe and compare tissue 
responses between three treatment groups; no infusion, 3.3% NAC solution, and Lactated 
Ringer’s Solution (LRS).  Due to the possibility of negative side effects and the 
physiology of the guttural pouch, the uterus will be used as the site of irrigation.  The 
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epithelial tissue of the guttural pouch is similar to that of the uterus – both are mucosal 
tissues composed of columnar ciliated cells intermixed with mucus secreting goblet cells 
(Aughey and Frye, 2001; Causey et al., 2000).  The major difference is that the guttural 
pouch is a pseudo-stratified tissue, while the uterus is a single layer (Perkins et al., 2003; 
Aughey and Frye, 2001).  One of the keys to reducing strangles disease is treating the 
carrier state, and NAC has the potential to effectively cleanse the guttural pouch of S. 
Equi after strangles infections due to its mucolytic properties.  This study will use an 
endoscope to look for negative side effects of using a diluted NAC solution in the uterus. 
Several other studies have assessed the inflammatory response of uterine tissues to NAC 
using cytology and biopsy methods (Melkus et al., 2011; McGhie – unpublished); 
however, these studies have not employed the use of an endoscope for visual assessment.  
 
4. Materials and Methods 
4.1 Randomization of Horses 
Ten Standardbred mares from the J. F. Witter Teaching and Research Center were 
randomly assigned to three treatment groups; no infusion (4), LRS (3), and NAC (3). 
These horses were first ordered alphabetically and then given a random, three digit 
number generated by an online database (www.random.org).  The horses were then re-
ordered numerically and systematically assigned to the treatment group.  The table used 
for this randomization process has been duplicated on the next page – in which columns 
one and four were filled first, followed by column two and column three (see Table 1).   
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Table 1: Process of Randomization 
 
Names -
Alphabetical 
Randomly 
Assigned  # 
*Name –  
by Number 
Treatment Group 
Andy 281 Whiteout No infusion 
**Annie 229 Ford LRS 
Blisstex 898 Annie NAC 
Dewey 528 Andy No infusion 
Ford 119 Dewey LRS 
Holly 942 Honor NAC 
Honor 665 Jill No infusion 
Jill 755 Wicky LRS 
Whiteout 111 Blisstex NAC 
Wicky 834 Holly No infusion 
*This column was filled in last. 
**Upon arrival of Annie, her name was changed to Laney; Laney will be used for the rest 
of this paper. 
 
 
4.2 Preparation of Infusions 
 The infusions were prepared within four hours prior to irrigation.  The LRS 
infusions contained 180 mL of Lactated Ringer’s Solution (Hospira Inc.; each 100 mL 
contains 600 mg sodium chloride, 310 mg sodium lactate-anhydrous, 30 mg potassium 
chloride and 20 mg calcium chloride-dihydrate).  The NAC infusions were made using 
150 mL LRS and 30 mL of 20% Acetylcysteine (American Regents Inc.) to make a 3.3% 
NAC solution.  These solutions were measured and stored in 250 mL LRS bags for easier 
transport to the barn.  
 
4.3 Irrigation Procedure 
Prior to irrigation, each horse was trans-rectally palpated and the uterus was 
viewed by ultrasound.  This was done to ensure that the uterus did not have any pre-
existing fluid accumulation as well as to determine the stage in the heat cycle.  Horses 
that displayed anxious behaviors in the stocks were mildly sedated with 5 or 10 mg of 
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detomidine hydrochloride (Dormosedan, Pfizer).  The tail of the horse was wrapped using 
a non-sterile palpation sleeve and bandage tape, and tied around the neck to give clear 
access to the vulva.  The vulva was then repeatedly washed using cotton soaked in warm 
water and an iodine scrub (Prepodyne Scrub, West Agro).  An insemination pipette was 
then vaginally inserted through the cervix to the uterus using a sterile palpation sleeve 
and non-spermicidal sterile lube (Priority Care).  The uterus was then irrigated with either 
LRS or NAC depending on the assigned treatment group.  Horses in the no infusion 
treatment group only underwent the endoscopy procedure detailed below.  
 
 
4.4 Endoscopy Procedure 
The endoscopy procedure was performed on all horses from the no infusion 
treatment group and on all horses in the LRS and NAC groups 48 hours after irrigation. 
Prior to endoscopy, the tail of each horse was wrapped and the vulva was washed as 
described in section 4.3. Horses that displayed anxious behaviors were mildly sedated 
with 5 or 10 mg of detomidine hydrochloride (Dormosedan, Pfizer).  A 9mm diameter 
flexible endoscope (Fujinon 4400) was then inserted into the uterus through the vagina 
and cervix.  A sterile palpation sleeve and non-spermicidal sterile lube (Priority Care) 
were used for this process.  A video and several still frame images of the uterus were 
collected for each horse.   
 
5. Results  
The still frame endoscopic images collected during this study were reviewed and 
subjectively scored for the presence (given a score of one) or absence (score of zero) of 
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several traits that are indicative of inflammation.  The traits assessed included; 
hyperemia, edema, patchy inflammation, petechial hemorrhage, exudate, and transudate.  
The scoring was completed by a researcher blinded to both the treatment group and 
image origin.  After scoring, a cumulative score was summed and the treatment group 
and horse name were revealed.  The image scores for each horse are recorded in Table 2 
and correlated to the treatment group in Table 3. One of the assessed images from each 
horse follows to support the score given to each uterus (Figures 1-10).   
 
Horses 1, 2, 3 and 10 belonged to the no infusion treatment group and had 
cumulative scores of zero, zero, one, and zero respectively.  Horses 4, 7 and 9 belonged 
to the NAC treatment group and had scores of two, one, and one respectively.  All of 
these uteri exhibited signs of hyperemia, and the uterus of Horse 4 had several areas with 
increased redness – classified as patchy inflammation.  Horses 5, 6 and 8 were infused 
with LRS and had uterine scores of three, two, and two respectively.  All of these uteri 
also exhibited signs of hyperemia.  Additionally, higher degrees of irritation were noted 
for the horses that received the LRS infusion.  The inflammatory signs noted included: 
two uteri with edema, one with petechial hemorrhage, and one with transudate.  These 
results indicate that irrigation of either NAC or LRS will cause increased tissue irritation 
and inflammation when compared to horses in the no infusion group.  Additionally, 
horses in the LRS group demonstrated greater degrees of inflammation in comparison to 
the horses from the NAC group. 
  
 
 
1
2 
 
 
 
Table 2: Subjective Evaluation of Endoscopic Images of the Uterus 
 
Uterus Trait #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 
Hyperemia  0 0 1 1 1 1 1 1 1 0 
Edema 0 0 0 0 1 0 0 1 0 0 
Patchy Inflammation 0 0 0 1 0 0 0 0 0 0 
Petechial Hemorrhage 0 0 0 0 1 0 0 0 0 0 
Exudate 0 0 0 0 0 0 0 0 0 0 
Transudate 0 0 0 0 0 1 0 0 0 0 
Total  0 0 1 2 3 2 1 2 1 0 
                                                      
*Group Condition  
No
Infusion 
No 
Infusion 
No 
Infusion NAC LRS LRS NAC LRS NAC 
No  
Infusion 
*Horse Name Holly Whiteout Andy Honor Dewey Wicky Laney Ford Blisstex Jill 
 
Zero indicates absence of trait.  
One indicates the presence of a trait. 
*The information in these rows was not made available until after all images were scored.   
 
 
 
 
 
 
 
  
 
1
3 
 
 
 14 
 
 
 
 
Figure 1 - Horse #1 (above): Holly – score of zero. 
 
Figure 2 - Horse #2 (below): Whiteout – score of zero.  
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Figure 3 - Horse #3 (above): Andy – score of one; hyperemia.  
 
Figure 4 - Horse #4 (below): Honor – score of two; hyperemia & patchy inflammation.  
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Figure 5 - Horse #5 (above): Dewey – score of 3; hyperemia, edema & petechial 
hemorrhage. 
 
Figure 6 - Horse #6 (below): Wicky – score of 2; hyperemia & transudate.  
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Figure 7 - Horse #7 (above): Laney – score of one; hyperemia.  
 
Figure 8 - Horse #8 (below): Ford – score of two; hyperemia & edema.  
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Figure 9 - Horse #9 (above): Blisstex – score of one; hyperemia. 
 
Figure 10 - Horse #10 (below): Jill – score of zero.  
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Figure 11 – Image Captured from Video of Horse #3 (above): This video segment 
revealed petechial hemorrhage in Andy, a horse from the no infusion treatment group.  
 
 
 
 
6. Discussion 
In general, the irrigation and endoscopy procedures were well tolerated by the 
mares involved in this study, and only mild and localized signs of tissue irritation were 
observed.  No sedatives were administered during irrigation.  Five horses received 
sedation for the endoscopy procedure, however; two of these horses were also involved in 
dental procedures during the same time period and may not have needed sedation solely 
for the endoscopy procedure.  
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Andy (horse #3) was the only horse in the no infusion treatment group that 
showed evidence of inflammation upon endoscopy.  The still frame images showed 
evidence of hyperemia and the uterus was given the score of one. This can be partially 
explained because the initial endoscopy video collected for this mare did not record.  
Two days later, this horse underwent a second endoscopy procedure to replace the data.  
The presence of hyperemia therefore may be associated with cervical penetration.  If this 
is the case, horses infused with NAC or LRS may show hyperemia in response to 
penetration and this indication of inflammation might not be in direct response to the 
LRS or NAC solutions. Additionally, an area containing petechial hemorrhage was 
discovered upon review of the video for Andy (see Figure 11). Video findings were not 
evaluated in this study and Table 2 does not reflect this finding. This incidence of 
petechial hemorrhage is caused by mechanical damage from the endoscope and cannot be 
attributed to an infusion since this mare was in the no infusion treatment group.   
 
Transudate and petechial hemorrhage were two greater degrees of tissue irritation 
seen for the LRS treatment group.  The petechial hemorrhage seen in the uterus of Dewey 
(horse #5) could have resulted from the insemination pipette or the endoscope scraping 
the uterine tissues as was similarly found in Andy (horse #3).  Additionally, the reddish-
brown fluid labeled as transudate found in Wicky (horse #6) was not sampled for testing 
and can therefore not be identified with certainty.  Both of these findings could be a result 
from pre-existing uterine damage or mechanical damage as a result of this study, and may 
not be directly caused by the LRS solution.  Future studies should consider collecting 
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initial endoscopic images before irrigation which may help distinguish the direct cause of 
these two types of inflammatory responses. 
 
There is a clear relationship between the cumulative uterine score and the 
treatment group (see Table 3).  Horses in the no infusion group showed no or limited 
inflammation, and horses in the NAC treatment group showed less signs of tissue 
irritation when compared to horses from the LRS treatment group.  Since the 3.3% NAC 
solution was made by diluting 20% acetylcysteine in Lactated Ringer’s Solution, these 
results indicate that NAC has an anti-inflammatory effect.  A few other recent studies 
have similarly found that NAC is anti-inflammatory when compared to saline treatments 
(Melkus et al., 2011; LaBlanc, 2010).  LaBlanc (2010) states; “Data indicated that NAC 
was not harmful to the endometrium and that it may counteract the irritating effect of 
saline.”  
 
Future studies should continue to evaluate the anti-inflammatory properties of 
NAC through blinded, scientific studies.  Additionally, varying concentrations of NAC 
should be tested and other time intervals should be used to verify that NAC is only mildly 
irritating to mucosal tissue.  Testing in the uterus has provided many benefits to this 
study, and although continuing studies should use this organ, tissue response to NAC 
irrigations applied to the guttural pouch also need to be evaluated.  It is recommended 
that further studies evaluate the safety of infusing a 3.3% NAC solution into the guttural 
pouch as well as test NAC for efficacy as a mucolytic agent in the treatment of horses 
carrying S. equi after strangles outbreaks. 
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It must be noted that the techniques of irrigation and endoscopy may limit the 
practicality of infusing the guttural pouch with NAC as a treatment for strangles.  These 
techniques may not be easily adaptable to field work and may be better suited for use in 
hospital settings.  Irrigation of the guttural pouch requires the use on an endoscope, and 
this equipment is too bulky and expensive to be used widely by practitioners in the field.  
 
7. Conclusions and Implications 
 The results of this observational study show that intrauterine infusions of NAC 
and LRS cause increased irritation to epithelial tissue when compared to horses from the 
no infusion treatment group.  Additionally, the uteri infused with NAC showed less 
inflammatory response when compared to those infused with LRS indicating that NAC 
could have anti-inflammatory affects on mucosal tissues.  All inflammatory responses 
were mild and localized to the uterus.  Evidence from this study suggests that NAC does 
have the potential to be a low-risk treatment option for the carrier state of strangles. 
Further testing will be needed to verify the anti-inflammatory properties of NAC as well 
as to evaluate the efficacy of cleansing the guttural pouch of horses involved in strangles 
outbreaks with NAC.   
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Appendix 1 – IACUC Approval 
 
PROTOCOL NUMBER:       August 2010 version 
UNIVERSITY OF MAINE 
PROTOCOL REVIEW FORM 
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE 
 
GENERAL INSTRUCTIONS:  The Institutional Animal Care and Use Committee (IACUC) 
consists of scientists from several disciplines as well as non-scientists, members of the University 
community, and persons who have no other affiliation with the University than as members of the 
Committee.  The protocol should therefore be described in terms understandable by an audience 
of educated nonspecialists.  Please return the completed protocol to the Institutional Animal 
Care and Use Committee, c/o Office of the Vice President for Research, 114 Alumni Hall.  
The form is due TWO weeks prior to a scheduled IACUC meeting.  The meeting dates are 
posted at: http://www.umaine.edu/research/research-compliance/institutional-animal-care-
and-use-committee-iacuc/meeting-schedule-and-protocol-due-dates/.  Protocols received late 
will be held until the next month’s meeting.  Please call Gayle Jones at 1-1498 if you have 
questions.      
 
The Principal Investigator or Instructor must justify the ethical costs of using live animals by 
demonstrating a reasonable expectation that such usage will contribute to the advancement of 
knowledge which may eventually benefit humankind and/or animals.  The Principal Investigator 
or Instructor must further demonstrate that he or she has applied the concepts of "alternatives" in 
designing the protocol.  The term “alternatives” includes three components:  replacement (using 
organisms that are phylogenetically lower, cell cultures, tissues from slaughter or autopsy, or 
nonanimal systems); reduction (in the number of animals used); and refinement (of design and 
methods to reduce pain and stress to animals used as well as ensuring that the number of animals 
used is optimal for the analysis proposed).   
 
 1. Principal Investigator, Co-Investigator(s), or Instructor(s), with campus address, office 
phone, and lab phone of PI (NOTE:  The Principal Investigator or Instructor must be a 
faculty member or professional staff): 
 
PI: Robert Causey Associate Professor, Animal and Veterinary Sciences,  
Hitchner Hall Tel:  581-2782 
 
CI: Christine Kissinger (AVS Capstone/Honors student) 
  
Title and number of course/Title of project:   
 
Endoscopic evaluation of  the response to intrauterine irrigation with 3.3 % N 
Acetyl Cysteine 
 
Project/Course Start Date: February 1, 2012 
 
Number of years project is planned to continue: Three  
(IACUC approval is granted for three years) 
If this is a renewal application, please enter the exact project or course title and previous protocol 
code.  Be sure to identify any changes from the previously approved protocol.   
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 Funding agency for project, if applicable.  Include title of proposal if different from this 
protocol.   
 
 Maine Technology Institute/Maine Technology Asset Fund: Commercialization of 
New Technologies for Animal Disease Surveillance 
 
 
2. Describe the (check appropriate category) __X__research, __X__teaching, or 
____production objectives (not procedures) that involve use of animals.  Explain these 
objectives in non-technical language.  Do not paste in sections of grant proposals. 
 
To detect and describe by endoscopic examination of the equine uterus the 
occurrence of irritation caused by intrauterine infusion of N - acetyl cysteine. 
 
3. Describe how this use of animals contributes to the advancement of knowledge, which 
may eventually benefit humankind and/or animals. 
 
Infertility in the mare is a serious cause of economic loss to horse owners. In 
addition, infertile mares quickly lose their value and run the risk of being sold, discarded or 
abandoned. Methods to treat infertility in mares therefore benefit both horse owners and 
maintain the value of breeding stock. 
Recently 3.3% N-acetyl cysteine (NAC) in lactated ringers solution (LRS) has shown 
promise as an anti-inflammatory and mucolytic agent when infused in the equine uterus, 
and has been associated with improved conception rates. In contrast, 20 % N-acetyl cysteine 
administered in the guttural pouch has been associated with mucosal irritation as detected 
by endoscopy. We therefore wish to determine if N-acetyl cysteine, used at 3.3% strength, 
shows signs of irritation in the uterus, which may be a contraindication for its use.  
Because this is the first time an endoscopic evaluation of the uterus has been 
performed post NAC infusion, it is necessary to classify this as a pilot-study in which 
variation to infusion may be estimated, preparatory to possible follow-up studies. 
 
4. Identify the animals to be used (genus and species) and number (for the entire project). 
 
Equus caballus  12 total,  4 treatment animals (3.3% NAC in LRS), 4 animals 
infused with LRS only and 4 uninfused controls. 
 
5.   State the rationale for use of this/these species.  Address the issue of replacement by 
explaining why educational or research objectives cannot be met by the use of 
phylogenetically lower organisms, cell or tissue cultures, or non-animal systems.  (Please 
note:  the IACUC does not consider "hands-on experience" to be in and of itself an 
adequate educational objective, unless the course serves students whose anticipated 
educational and professional futures will require the skills imparted through such hands-
on experience.  If that is true in this instance, please describe the student population that 
typically enrolls in the course.) 
 
There is no substitute for the live horse in this study because the horse tends to be 
idiosyncratic in its response to uterine infusions. Consequently there is no in-vitro or 
computerized model which we can use to confidently predict response to infusion with 
NAC, nor could results in a phylogenetically lower organism be extended with confidence to 
the horse. 
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6. Justify the number of animals: 
 
a. Explain how the number of animals required fits your experimental design or 
teaching or production/breeding objectives. 
 
We are planning a descriptive pilot - study involving 4 animals treated with 
NAC, 4 treated with LRS, and 4 un-infused animals. Assessment of acute endometrial 
irritation is based on visual inspection of endometrial hyperemia (redness due to increased 
arterial blood flow), hemorrhage, edema and exudate. The internal medicine literature 
describing irritation of the equine guttural pouch infused with 20 % NAC raises sufficient 
questions about the potential irritation caused by NAC to justify this study.    
 
b. Give the rationale for the number in terms of the statistical methods to be used.  
Address the issue of reduction by explaining why the proposed number is 
sufficient, but not excessive.  (A simple statement that the number proposed is 
required for statistical significance is not an adequate response.)  See How to do 
a Power Analysis.  For research in which the number of animals is limited not by 
statistical power, but by the number of animals that can be captured, maintained, 
or sampled, a power analysis will provide an indication of the statistical power of 
the proposed tests based on the variance measured by the researcher, or others, in 
previous studies.  For studies not amenable to a Power Analysis (e.g., no data on 
variability available, only descriptive data available), provide a justification for 
why a power analysis is not appropriate for your project.  
 
 
  The number requested is adequate because this is a pilot study and no 
formal statistical analysis is proposed.  
 
7. PROCEDURES 
 
The Committee does not wish to receive copies of research proposals or laboratory manuals.  The 
Principal Investigator or Instructor is asked to address succinctly the following questions, 
as applicable.  Special care should be taken to justify any procedures generally 
discouraged by the University's code of ethics and policy.  
 
a. Major categories of procedures.  Please check the appropriate box for each 
category.   
 
 Any “yes” responses must be described in sections b. (nonsurgical 
procedures) and/or c. (surgical procedures) that follow.  Please attach the 
category headings (from 1-16 below) to the description of procedures in 
sections 7b and c. 
 
Yes No 
 
 X 1. collection or capture 
 X 2. kill and harvest tissue 
 X 3. immunization for antibody production:  describe antigen, adjuvant used, 
route of immunization, method of obtaining blood 
X  4. physiologic measurements 
 X 5. dietary manipulations 
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X  6. pharmacology/toxicology:  material used, route of administration, etc. 
   3.3 % NAC in lactated ringers solution administered intrauterinely 
 X 7. behavior studies 
 X 8. environmental stress, e.g., temperature, restraint, forced exercise 
 X 9. irradiation:  type, facility to be used 
 X 10. hazardous materials, e.g., carcinogens, radioactive materials 
 X 11. biohazardous or infectious agents (use of Class 2 or higher agents 
requires the approval of the University's Biosafety Committee)  
 X 12. experimental trauma 
 X 13. nonsurvival surgical procedure 
 X 14. survival surgical procedure (animal is allowed to recover for any length 
of time) 
 X 15. multiple major operative procedures from which animal is allowed to 
recover   
X  16. other, specify:  
  Uterine infusion and uterine endoscopy 
 
b. Nonsurgical Procedures: 
 
Describe all nonsurgical manipulations or procedures, if any, involving the 
animal, e.g., drug administration, blood collection, diet change, collection, 
capture.  Specify the drug(s), dose, route of administration, or other methods 
used.  Specify duration of procedures.  If an adjuvant will be used, state the 
number of injection sites per dosage and the number of doses. 
 
Using aseptic technique a sterile solution of 30 mL of a 20% solution of NAC 
combined with 150 mL of sterile lactated ringers solution will be introduced 
into the uterus of 4 mares. An additional 4 mares will receive 180 mL 
lactated ringers solution only.  Twenty four hours following infusion the 
perineal region will be aseptically prepared and a chemically sterilized, 9mm 
diameter flexible endoscope introduced per vaginam into the uterus, and the 
endometrium visualized and recorded digitally. Following endoscopy of all 
mares images of the uteri will be examined as a group and endometria 
indicating irritation will be identified. Assessment of irritation will be made 
by an individual (the PI) blinded to whether the horse received an infusion 
of NAC or saline. 
 
Uterine endoscopy and uterine infusion are routine procedures in the mare 
which may be performed without sedation. However, sedation will be 
administered if the mare appears anxious (detomidine hydrochloride - 5 or 
10 mg IV). This is a routinely used method of sedation well tolerated by 
horses. Sedated horses will be allowed time to regain full consciousness in 
their stall, hay and water having been removed to prevent choking hazards, 
and then turned back out onto pasture when fully alert. 
 
Examinations will not exceed 10 minutes, and will be curtailed if evidence of 
irriation associated with endoscopy is detected.  
  
 
Will the animals be killed?  If so, what method of euthanasia will be used?  
(Include dosages if applicable.)  See the 2007 Report of the AVMA Panel on 
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Euthanasia for assistance 
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf).  If not, what final 
disposition of the animals is planned? 
 
NO. Animals will remain part of the UMaine Standardbred herd at the 
Witter Center. 
 
If euthanasia becomes necessary, due to unplanned injury or illness to the 
animal(s), how will it be accomplished (include dosages if applicable)?  See the 
2007 Report of the AVMA Panel on Euthanasia for assistance 
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf). NOTE:  question 
must be answered. 
 
If necessary, euthanasia will be performed by rapid intravenous 
administration of 100 ml of 390 mg/mL Sodium pentobarbital with 50 
mg/mL sodium phenytoin (euthanasia solution) by one of the attending 
veterinarians from Foxcroft Veterinary Services, Dover-Foxcroft, ME. 
 
 
c. Surgical Procedures: 
 
Describe briefly any surgical procedures.  Describe the anaesthetic method, 
including all drugs, dosages, routes of administration, and supplementation 
schedules.  Describe the postsurgical monitoring and care procedures, including 
what response(s) you will look for to indicate recovery, and the method of 
euthanasia (if it becomes necessary due to unplanned injury or illness).   
 
N/A 
 
Is animal allowed to recover for any length of time?  Yes/No   If yes, how long 
will animal survive surgery?  
 
N/A 
 
If there is potential for discomfort or pain as a result of the procedures, describe 
their nature and duration.  Explain what will be done to relieve them, including 
drugs and dosages, nursing care, mechanical devices, etc. 
 
N/A 
 
d. Search for Alternatives:  If the proposed procedures cause more than momentary 
or slight pain or distress to the animal(s), federal regulations require that you 
search for alternatives.  The PI must provide a written narrative description (see 
NOTE below) of the sources used to determine that less painful alternatives are 
not available.  To fulfill this requirement, bibliographical searches may be 
performed through the Animal Welfare Information Center (AWIC) of the 
National Agriculture Library 
(http://awic.nal.usda.gov/nal_display/index.php?info_center=3&tax_level=1&tax
_subject=184). 
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 Will the proposed procedures cause more than momentary or slight pain or distress to the 
animal(s)? 
 
 X No.  (Examples of procedures for which this response is appropriate include 
observation of behavior under conditions of little or no distress, dietary 
manipulations, and injections or blood sampling by qualified personnel.) 
 
 
 Yes.  (Examples of procedures for which this response is appropriate 
include survival surgery, nonsurvival surgery, electrofishing, and 
procedures producing pain or distress unrelieved by analgesics such as 
toxicity studies, microbial virulence testing, radiation sickness, and 
research on stress, shock, or pain.)  The required narrative is attached.   
 
 NOTE:  When preparing the narrative, the instructions in the USDA 
policy MUST be followed.  For a description of this policy, see: 
http://www.aphis.usda.gov/animal_welfare/downloads/policy/policy1
2.pdf. 
   
 NOTE:  When proposed procedures will cause more than momentary or 
slight pain or distress to animal(s), a consultation with the attending 
veterinarian must occur in the planning stages of those procedures 
prior to submitting this protocol for review.  Please email Dr. James 
Weber, james.weber@umit.maine.edu, with a description of the 
proposed procedures and your approach to minimizing pain/distress.   
 
8. Animal Sources and Housing    
 
a. Please indicate source of animals.  Note:  The IACUC will approve animal purchases 
from a licensed pet store provided the researcher/instructor informs the pet store 
(in writing) that the purchased animals will be used for research/teaching.   
UMaine Standardbred Herd 
 
b. If the animals are caught in the wild: 
 N/A 
 Where and how will the animals be trapped?   
 N/A 
 How often will the traps be checked?   
 N/A 
 What other steps will be taken to protect the animals from exposure or other danger?   
 N/A 
 Indicate if Federal/State permits are required and whether they have been obtained.   
 N/A 
 If the animals will be brought to the campus, what precautions will be taken to prevent 
zoonotic diseases?   
 N/A 
 Please include your plans for removal of traps or barriers (e.g., pitfall traps).   
N/A 
 
c.   Where will the animals be housed?  Describe the housing (See the Guide for the 
Care and Use of Lab Animals 
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(http://www.nap.edu/readingroom/books/labrats/) pages 22-36) for 
information on Physical Environment, including space requirements.  If your 
housing will not meet the Guide requirements, include a request for an exception 
to the Guide.  If your animals are not listed in the Guide, housing should meet the 
recommendations of the appropriate guidelines for the proposed species.  Include 
dimensions of cage, tank, etc.    
 
J F Witter Teaching and Research Center 
 
d. Identify the room or facility in which the procedures will be conducted. 
 
Animal Handling Room 
 
 
 9. List all person(s) (including PI) who will handle animals (e.g., carry out the procedure(s), 
animal care, etc.) or provide training of personnel.  For each person named below, 
describe his/her experience in performing proposed procedures; if none, explain how 
training will be obtained.   
 
Name/Title/Experience 
 
Robert Causey DVM, PhD, Diplomate American College of Theriogenologists. Has 
experience of uterine infusion and endoscopy in teaching, clinical and research settings. 
 
Christine Kissinger: Senior student. This project is her capstone/honors thesis and all 
her work will be carried out under the supervision of the PI. 
        
 
10. If animals will be housed, please list the name, phone number, and email of the person 
who should be contacted to accompany the IACUC during facility inspections: 
 
Robert Causey 581-2782 email on first class 
 
11. Have all personnel named above been certified by the IACUC for Responsible Care and Use 
of Animals?   
X  Yes      No     A web-based tutorial for this certification is available at:  
http://umaine.edu/research/research-compliance/institutional-animal-care-and-use-committee-
iacuc/web-based-training/.  (Note:  protocols will not be processed until all personnel have 
been certified.) 
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12. Risk Assessment (risks to researchers): 
 
 In compliance with our Public Health Service Animal Welfare Assurance, we have 
implemented an Occupational Health/Medical Surveillance Program.  The first step will 
be for investigators to identify potential hazards with tasks involved with the study, so the 
IACUC veterinarian and Safety and Environmental Management (SEM) can assess the 
risks to determine if further information will be required from everyone named in the 
protocol (i.e., a health questionnaire).   
 
 Please complete the following for your proposed protocol. 
 
 
a) Provide a brief description of the protocol (cut and paste response from question 
2 of the protocol).  (NOTE:  Only this page, not the whole protocol, goes to SEM and the 
Occupational Health Physician, thus the request for duplication of the answer to question 
2.)  
 
To detect and describe by endoscopic examination of the equine uterus the 
occurrence of irritation caused by intrauterine infusion of N- acetyl cysteine. 
 
 b) List the tasks required. 
 
 1. Uterine Endoscopy 
 2. Uterine infusion 
 3.  
 
 c) For each of the tasks described in b) above, list the associated hazards. 
 
  1. Horse resisting procedures leading to injury of people 
  2. 
  3. etc. 
 
d) For each of the hazards described in c) above list how the hazards will be 
managed. 
 
  1. Chemical Restraint (sedation) if necessary 
  2. Physical Restraint (stocks) 
  3. Animal handlers trained by and under supervision of PI. 
 
NOTE: In evaluating this risk assessment statement, we will be looking for animal care tasks that 
increase the risk of illness (such as a zoonotic disease), physical injury (such as animal bites), 
and/or allergic reactions to those handling the animals. 
 
After this risk assessment is reviewed, everyone named in the protocol may be required to 
complete a health questionnaire.  The health questionnaire may require review by the 
Occupational Health Physician.  If so, there is a charge for this review, and you will be 
required to provide an account number.  (Currently the charge is $45; we do not know the 
cost of a physical exam if warranted after review of the questionnaire, but this page will be 
updated when that information is known.)   
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If you have any questions regarding the completion of this page, please contact James 
Patrick, Safety and Environmental Management, 1-4055.   
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